SCHEMBL8001635

SCHEMBL8001635

Cc1c(C(=O)Nc2cccc(Cl)c2)nnn1-c1ccc(F)nc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
ALDH1A1 P00352 1/20 0.58
LMNA P02545 1/20 0.58
HTT P42858 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
RIPK1 Q13546 1/20 0.48
TP53 P04637 4/20 0.47
MET P08581 3/20 0.46
RAB9A P51151 1/20 0.45
SMURF1 Q9HCE7 1/20 0.45
CCR1 P32246 1/20 0.45
CCNC P24863 1/20 0.45
CDK8 P49336 1/20 0.45
NR1I2 O75469 1/20 0.44
GRM4 Q14833 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986777 0.90 MEN1 (0.60) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3407265 0.87 MAPT (0.65) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3407140 0.85 MAPT (0.60) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3403988 0.84 SMN1; SMN2 (0.64) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3403675 0.84 MAPT (0.78) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3406096 0.83 MAPT (0.62) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3405841 0.82 MEN1 (0.53) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3407283 0.80 SMURF1 (0.59) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3404049 0.79 MAPT (0.55) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3400866 0.78 MAPT (0.58) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009115486-A1 TRIAZOLE AMIDE DERIVATIVES FOR USE IN THERAPY GLAXO GROUP LIMITED (GB) 2009-09-24 WO disclosed